1. Home
  2. ARW vs KRYS Comparison

ARW vs KRYS Comparison

Compare ARW & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARW
  • KRYS
  • Stock Information
  • Founded
  • ARW 1935
  • KRYS 2015
  • Country
  • ARW United States
  • KRYS United States
  • Employees
  • ARW N/A
  • KRYS N/A
  • Industry
  • ARW Electronic Components
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ARW Technology
  • KRYS Health Care
  • Exchange
  • ARW Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • ARW 5.8B
  • KRYS 4.7B
  • IPO Year
  • ARW N/A
  • KRYS 2017
  • Fundamental
  • Price
  • ARW $104.54
  • KRYS $207.89
  • Analyst Decision
  • ARW Sell
  • KRYS Strong Buy
  • Analyst Count
  • ARW 2
  • KRYS 9
  • Target Price
  • ARW $102.00
  • KRYS $214.22
  • AVG Volume (30 Days)
  • ARW 783.2K
  • KRYS 326.5K
  • Earning Date
  • ARW 10-30-2025
  • KRYS 11-03-2025
  • Dividend Yield
  • ARW N/A
  • KRYS N/A
  • EPS Growth
  • ARW 0.79
  • KRYS 275.72
  • EPS
  • ARW 9.05
  • KRYS 6.66
  • Revenue
  • ARW $29,389,382,000.00
  • KRYS $373,164,000.00
  • Revenue This Year
  • ARW $9.85
  • KRYS $34.33
  • Revenue Next Year
  • ARW $5.17
  • KRYS $48.04
  • P/E Ratio
  • ARW $11.70
  • KRYS $31.35
  • Revenue Growth
  • ARW 3.16
  • KRYS 54.51
  • 52 Week Low
  • ARW $86.50
  • KRYS $122.80
  • 52 Week High
  • ARW $134.74
  • KRYS $212.98
  • Technical
  • Relative Strength Index (RSI)
  • ARW 26.03
  • KRYS 70.35
  • Support Level
  • ARW $110.00
  • KRYS $198.02
  • Resistance Level
  • ARW $113.19
  • KRYS $209.96
  • Average True Range (ATR)
  • ARW 3.32
  • KRYS 8.66
  • MACD
  • ARW -0.58
  • KRYS 0.27
  • Stochastic Oscillator
  • ARW 4.37
  • KRYS 87.11

About ARW Arrow Electronics Inc.

Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: